Beijing Beilu Pharmaceutical Co., Ltd. (SHE:300016)
China
· Delayed Price · Currency is CNY 11.19
+0.21 (1.91%)
Mar 10, 2026, 3:04 PM CST
Beijing Beilu Pharmaceutical Company Description
Beijing Beilu Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products in China.
The company provides contrast agents, such as gadopentetate meglumine injection, gadobutrol injection, and gadobenate meglumine injection for MRI contrast; and iohexol injection, iopamidol injection, and iodixanol injection for CT contrast, as well as glimepiride and repaglinide tablets and jiuwei zhenxin granules.
It also offers gadolinium-based agents, including gadopentetate dimeglumine and gadobutrol, as well as iodine-based agents comprising iohexol, ioversol, iodixanol, iopromide, and iopamidol, as well as oral anti-diabetic drugs.
The company was founded in 1992 and is based in Beijing, China.
Beijing Beilu Pharmaceutical Co., Ltd.
| Country | China |
| Founded | 1992 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 1,173 |
| CEO | Xu Wang |
Contact Details
Address: Maples International Office Beijing, 100082 China | |
| Phone | 86 10 6262 2266 |
| Website | beilu.com.cn |
Stock Details
| Ticker Symbol | 300016 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE000001QK9 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Xu Wang | Chairman and GM |
| Ni Zeng CPA | Deputy GM, Chief Financial Officer, Accounting Supervisor and Non-Independent Director |
| Sen Li | Executive Vice President and Chief Operating Officer |
| Li Zong | Deputy GM and Director |
| Zehui Shao | Deputy GM, Secretary of the Board of Directors and Non-Independent Director |
| Xiasi Kuang | Deputy General Manager |
| Gen Chang Zheng | Chief Engineer and Employee Representative Member of Supervisory Board |